Baseline Genomic Features in
BRAF inhibitor
MEK inhibitor
baseline genomic alterations
metastatic melanoma
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
18 Aug 2019
18 Aug 2019
Historique:
received:
15
07
2019
revised:
08
08
2019
accepted:
09
08
2019
entrez:
21
8
2019
pubmed:
21
8
2019
medline:
21
8
2019
Statut:
epublish
Résumé
In
Identifiants
pubmed: 31426590
pii: cancers11081203
doi: 10.3390/cancers11081203
pmc: PMC6721518
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Assistance Publique - Hôpitaux de Paris
ID : undefined
Organisme : Université de Paris
ID : undefined
Organisme : la société française de dermatologie
ID : undefined
Organisme : Fondation de l'Avenir pour la Recherche Médicale Appliquée
ID : undefined
Références
Ann Transl Med. 2016 Jun;4(12):237
pubmed: 27429963
N Engl J Med. 2010 Aug 26;363(9):809-19
pubmed: 20818844
N Engl J Med. 2012 Jul 12;367(2):107-14
pubmed: 22663011
Nat Rev Clin Oncol. 2017 Aug;14(8):463-482
pubmed: 28374786
Nature. 2011 Nov 23;480(7377):387-90
pubmed: 22113612
Future Oncol. 2019 Sep 1;15(25):2933-2942
pubmed: 30799646
Lancet Oncol. 2016 Sep;17(9):1248-60
pubmed: 27480103
Cancer Discov. 2014 Jan;4(1):80-93
pubmed: 24265155
Oncogenesis. 2018 Sep 20;7(9):71
pubmed: 30237393
Melanoma Res. 2014 Aug;24(4):415-8
pubmed: 24933605
Nat Commun. 2012 Mar 06;3:724
pubmed: 22395615
Mol Cancer Ther. 2013 Jul;12(7):1332-42
pubmed: 23645591
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
N Engl J Med. 2012 Feb 23;366(8):707-14
pubmed: 22356324
Cancer Metastasis Rev. 2017 Mar;36(1):53-75
pubmed: 28210865
Nature. 2012 Jul 26;487(7408):500-4
pubmed: 22763439
Nature. 2010 Dec 16;468(7326):973-7
pubmed: 21107323
Lancet. 2015 Aug 1;386(9992):444-51
pubmed: 26037941
Clin Cancer Res. 2017 Sep 1;23(17):5238-5245
pubmed: 28536307
Clin Cancer Res. 2014 Apr 1;20(7):1965-77
pubmed: 24463458
Cell. 2016 Mar 24;165(1):35-44
pubmed: 26997480
N Engl J Med. 2015 Jan 1;372(1):30-9
pubmed: 25399551
Cancer Res. 2011 Aug 1;71(15):5067-74
pubmed: 21803746
Nature. 2002 Jun 27;417(6892):949-54
pubmed: 12068308
Hum Pathol. 2013 Sep;44(9):1902-11
pubmed: 23664541
Cell. 2015 Jun 18;161(7):1681-96
pubmed: 26091043
Cancer Discov. 2014 Jan;4(1):94-109
pubmed: 24265153
Clin Cancer Res. 2019 Jun 1;25(11):3239-3246
pubmed: 30824584
Future Oncol. 2018 Aug;14(20):2045-2052
pubmed: 30081673
Pigment Cell Melanoma Res. 2012 Mar;25(2):248-58
pubmed: 22171948
Tumori. 2016 Oct 13;102(5):501-507
pubmed: 27470608
Oncotarget. 2019 Mar 1;10(18):1669-1687
pubmed: 30899440
Bioinformatics. 2009 Dec 15;25(24):3325-6
pubmed: 19808880
Cancer Cell. 2010 Dec 14;18(6):683-95
pubmed: 21156289
NPJ Precis Oncol. 2018 Mar 7;2(1):7
pubmed: 29872725
Nature. 2014 Apr 3;508(7494):118-22
pubmed: 24670642
Lancet. 2012 Jul 28;380(9839):358-65
pubmed: 22735384
N Engl J Med. 2014 Nov 13;371(20):1877-88
pubmed: 25265492
Eur J Cancer. 2015 Dec;51(18):2792-9
pubmed: 26608120
Lancet Oncol. 2014 Mar;15(3):323-32
pubmed: 24508103
Pigment Cell Melanoma Res. 2014 Nov;27(6):1154-8
pubmed: 25130256
Cancer Res. 2017 Nov 1;77(21):5820-5830
pubmed: 28947418